honokiol has been researched along with Glioblastoma with Sarcomatous Component in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Deng, C; Deng, L; Duan, X; Peng, C; Wang, N; Wang, X; Wei, Y; Wen, J; Yang, G; Zhang, X; Zhao, X; Zheng, H | 1 |
1 other study(ies) available for honokiol and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Female; Glioma; Gliosarcoma; Humans; Lignans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley | 2011 |